JGC
RMTI icon

J. Goldman & Co’s Rockwell Medical RMTI Stock Holding History

J. Goldman & Co’s Portfolio RMTI Stock Details RMTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-1,227
Closed -$1.54M – 285
2013
Q3 		$1.54M Buy
+1,227
New +$833K 0.14% 178

Other funds holding RMTI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

J. Goldman & Co's RMTI Position: Q2 2015 in Review

J. Goldman & Co sold out of Rockwell Medical (RMTI) in Q2 2015, closing a stake of 4,500 shares — an estimated $5.41M sold.

J. Goldman & Co first reported a position in RMTI in Q1 2015 and held it in 1 quarter. The position peaked at $5.41M in Q1 2015. 99 funds tracked by Wall St. Rank hold RMTI as of Q2 2015.

  • J. Goldman & Co reported no remaining Rockwell Medical position as of Q2 2015 after selling out during the quarter.
  • J. Goldman & Co sold 4,500 Rockwell Medical shares in Q2 2015, an estimated $5.41M.
  • J. Goldman & Co first reported a position in Rockwell Medical in Q1 2015 and held it in 1 quarter.
  • J. Goldman & Co's Rockwell Medical position peaked at $5.41M in Q1 2015.
  • 99 funds tracked by Wall St. Rank held Rockwell Medical as of Q2 2015.

Based on J. Goldman & Co's 13F filing for Q2 2015, filed 14 Aug 2015.